Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: John Curtis who wrote (1748)	5/27/2001 11:28:33 AM
From: Michael Brody	Respond to of 2344

John, Regarding the "first look" Theratope data. My questions are: When did the trial actually begin ? Has enough time passed with enough patients for us to obtain any info. on the Survival time of treated patients ? I guess that my understanding is that the clinical trial was sort of an ongoing test rather than having to wait for the trial to be fully enrolled before beginning. Please forgive my lack of Scientific understanding. Also, I wonder when you think we might see a report on the BLP 25 phase II results ? Thanks